SCHEMBL4864527

SCHEMBL4864527

CCNC(=O)NCc1cccc(N)c1.CCNC(=O)NCc1cccc([N+](=O)[O-])c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.60
OPRM1 P35372 1/20 0.55
OPRK1 P41145 1/20 0.55
ALDH1A1 P00352 3/20 0.50
ACKR3 P25106 1/20 0.47
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
GAA P10253 1/20 0.47
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46
NAMPT P43490 1/20 0.46
MAPT P10636 2/20 0.46
PSMB1 P20618 1/20 0.46
PSMB5 P28074 1/20 0.46
PSMB2 P49721 1/20 0.46
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4865028 0.92 PTPN1 (0.68) PTPN1OPRM1OPRK1ALDH1A1ACKR3
Hydrochloric Acid SCHEMBL4862364 0.88 PTPN1 (0.60) PTPN1OPRM1OPRK1ALDH1A1ACKR3
SCHEMBL4861269 0.87 NAMPT (0.53) ALDH1A1CYP2D6CYP2C9CYP2C19NAMPT
SCHEMBL4865811 0.83 NAMPT (0.65) PTPN1OPRM1OPRK1ALDH1A1ACKR3
SCHEMBL11628064 0.82 PTPN1 (0.53) PTPN1OPRM1OPRK1ALDH1A1ACKR3
SCHEMBL4864537 0.82 CYP2D6 (0.46) PTPN1OPRM1OPRK1ALDH1A1ACKR3
SCHEMBL13623008 0.80 ALDH1A1 (0.63) ALDH1A1KMT2AMEN1GAAMAPT
SCHEMBL29738559 0.80 NAMPT (0.59) ALDH1A1CYP2D6CYP2C9CYP2C19NAMPT
SCHEMBL15939311 0.80 NAMPT (0.59) ALDH1A1CYP2D6CYP2C9CYP2C19NAMPT
Hydrochloric Acid SCHEMBL1025685 0.79 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384963-B2 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase GLAXO GROUP LIMITED (GB) 2008-06-10 US disclosed